Oral Vitamin C Administration on Erythropoietin Dosing Requirement in End-Stage Renal Disease Patients on Regular Hemodialysis

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
The study aimed to evaluate the safety and efficacy of oral vitamin C administration on erythropoietin dosing requirement in end-stage renal disease patients on regular hemodialysis.
Epistemonikos ID: 2720c6693b16650fc66e2f3cf4a64c084ca2d5f2
First added on: Jul 22, 2025